Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2020 - Issue 2

Corpus Callosum Agenesis with Chorioretinal Abnormality (Aicardi Syndrome): An Educational Review Download PDF


Lalrameng Mawii, Khayati Moudgil
Cite this article
Mawii L & Moudgil K. Corpus Callosum Agenesis with Chorioretinal Abnormality (Aicardi Syndrome): An Educational Review . Pharmacophore 2020;11(2):36-9
Abstract

According to the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH), Aicardi syndrome is a genetic condition affecting about 1 in 105,000 to 167,000 new-borns in the United States. This disease primarily affects females and is characterized by infantile spasms, partial or complete agenesis of corpus callosum (white holes) and characteristic lucan-shaped chorioretinal lesions (eye defects). Signs normally occur between the ages of 2 and 5 months, marked by a form of seizure in children, wheezing, and the appearance of yellowish spots in the eye, which may lead to epilepsy in later stages. There is no particular medication available for Aicardi Syndrome, but signs and causes can be resolved through therapy‎.

QR code:

Short Link:
Quick Access

Pharmacophore
 
ISSN: 2229-5402

By using this website, you agree to our Terms and Conditions, Privacy statement and Cookies policy.

Pharmacophore
© 2020 All rights reserved